Search

Displaying results 3411 - 3420 of 10000 in total
  1. Pathway

    Cardiolipin Biosynthesis CL(15:0/a-15:0/i-15:0/i-15:0)

    smpdb.ca/view/SMP0222515
    Metabolic

    Cardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition. It is essential for the optimal function of numerous enzymes that are involved in mitochondrial...

    Drugs: NADH · Cytidine-5'-Triphosphate · sn-glycerol 3-phosphate · Pyrophosphoric acid · Dihydroxyacetone phosphate
  2. Drug

    CALY-002

    go.drugbank.com/drugs/DB18378
    Investigational

    CALY-002 is a humanized monoclonal antibody targeting interleukin-15.

  3. Pathway

    Cardiolipin Biosynthesis CL(15:0/i-15:0/i-15:0/i-15:0)

    smpdb.ca/view/SMP0223025
    Metabolic

    Cardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition. It is essential for the optimal function of numerous enzymes that are involved in mitochondrial...

    Drugs: NADH · Cytidine-5'-Triphosphate · sn-glycerol 3-phosphate · Pyrophosphoric acid · Dihydroxyacetone phosphate
  4. Pathway

    Acylcarnitine (12Z,15Z)-10-Hydroxyoctadeca-12,15-dienoylcarnitine

    smpdb.ca/view/SMP0124337
    Metabolic

    (12Z,15Z)-10-Hydroxyoctadeca-12,15-dienoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, (12Z,15Z)-10-hydroxyoctadeca-12,15-dienoyl-CoA reacts with L-carnitine to form (12Z,15Z)-10-hydroxyoctadeca-12,15-dienoylcarnitine.

    Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 more
  5. Drug

    Elismetrep

    go.drugbank.com/drugs/DB15287
    Investigational

    Elismetrep is under investigation in clinical trial NCT02429102 (A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects).

  6. Drug

    Patritumab deruxtecan

    go.drugbank.com/drugs/DB21996
    Investigational

    Patritumab deruxtecan is under investigation in clinical trial NCT06596694 (Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)).

  7. Drug

    Milatuzumab

    go.drugbank.com/drugs/DB12943
    Investigational

    Milatuzumab has been used in trials studying the treatment of Lupus Nephritis, Multiple Myeloma (MM), GVHD (Acute or Chronic), Myelodysplastic Syndrome, and Chronic Lymphocytic Leukemia, among others.

  8. Drug

    MRK-003

    go.drugbank.com/drugs/DB17015
    Experimental

    MRK-003 is a potent and selective γ-secretase inhibitor developed by Merck. It is the preclinical analog of [MK-0752], a drug in clinical development.[A252682]

  9. Drug

    Calcium threonate

    go.drugbank.com/drugs/DB11168
    ApprovedWithdrawn

    L-threonate is an active metabolite of vitamin C that mediates a stimulatory action on vitamin C uptake [A27266]. … It is found in dietary supplements as a source of L-threonate used in the treatment of calcium deficiency and prevention of osteoporosis.

    Synonyms: Calcium L-threonateMixtures: Corvite 150, Ferrex 150 Forte Plus
  10. Drug

    SW033291

    go.drugbank.com/drugs/DB32765
    Experimental

    SW033291 is a small molecule 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibitor.